# R2-H — Formal Diagnostic Closure

**Status: R2 DIAGNOSTIC COMPLETE**  
**Closure baseline:** `da6bc7f34a520f3e1a26cb3034afcb502fb0a9a8`  
**Scope:** formal closure of the R2 diagnostic and governance record only.

## Closure determination

R2 is formally closed as a diagnostic phase. The inventory and R2-A through R2-E examined 54 source findings across 27 canonical findings (CFs); R2-F consolidated the source crosswalk. R2-G supplied an independent consolidation review. This record consolidates that evidence and the accepted governance decisions. It does not certify a product, approve implementation, or authorize R3.

## Evidence

- The source inventory, phase records, and consolidated crosswalk are recorded in the R2 review documents under `docs/reviews/`.
- The R2-G independent review, [R2 Independent Consolidation Review](r2-independent-consolidation-review.md), returned **PASS WITH NON-BLOCKING FINDINGS**.
- R2G-01 was subsequently verified as remediated by commit `3a3f1d3359e93a27a34f0a5aaa929a23cb245b9b`; only the two intended R2-F crosswalk rows changed, mapping `INV-07 → CF-09` and `R2B-03 → CF-09`. CI run [38331013030](https://github.com/hola675/NexoHarness/actions/runs/38331013030) passed.
- This closure baseline is `da6bc7f34a520f3e1a26cb3034afcb502fb0a9a8` on `main`, synchronized with `origin/main` and clean before this record was created. CI run [38332380030](https://github.com/hola675/NexoHarness/actions/runs/38332380030) passed on that SHA.
- Fresh local validation at the closure baseline passed: `npm run typecheck`, `npm run validate`, `npm test` (162/162), and `npm run verify:core`. The test suite includes the documentation-link resolution check. `git diff --check` is also required for this record before publication.

## Accepted governance decisions

ADR 0006, [Product V1 Scope and Adapter Priority](../decisions/0006-product-v1-and-adapter-priority.md), records the accepted DKT-01–06 decisions:

1. **V1 scope:** Canonical Model plus Kilo Code Adapter V1. Generic Installer, Observer runtime, automatic Promotion, and other harness targets are excluded.
2. **Target priority:** Kilo Code is the first product and certification target; Claude Code follows. Codex remains prior adapter research and model-validation work.
3. **Bundle eligibility:** one aggregate, fail-closed gate owned by the distribution assembler; Preview cannot be implicitly promoted.
4. **Distribution:** local, deterministic distribution bounded to the supported Kilo target, with paths, hashes, provenance, and completeness defined; generic signing and publication infrastructure are deferred.
5. **Installation:** one explicit, fail-closed installation scope. Unknown ownership or a collision means no write. Multi-scope operation, complex merges, sophisticated rollback, and auto-discovery are deferred.
6. **Observer:** runtime Task Observer and automatic Promotion are excluded from the first V1; their schemas and model remain available for later consideration.

The accepted V1 objective is to validate a harness-neutral canonical source and translate it deterministically, safely, and verifiably to Kilo Code while preserving semantics, authority, provenance, and eligibility gates.

## Deferred matters and limits

- The roadmap still documents the historical Codex → Claude Code → Kilo Code sequence. ADR 0006 establishes the accepted product priority. This closure does not edit the roadmap or authorize its reconciliation.
- The 14 R2 inventory matters remain diagnostic findings, not approved remediations. No code, schema, Policy, Directive, ADR, adapter, runtime, test, or roadmap remediation is authorized by this closure.
- R3 is not authorized. No implementation work is initiated here.
- Kilo Code has not been implemented or certified, and V1 is not complete or product-ready.
- No R1/R2 tag, release, automatic certification, or `phase:close` action is created or implied.

## Governance result

R2 diagnostic closure is recorded against the evidence above. Any roadmap reconciliation, technical remediation, R3 entry, or product certification requires its own explicit authorization and applicable review gate.
